Market Trends of Anti-retroviral Drugs Industry
This section covers the major market trends shaping the Anti-Retroviral Drugs Market according to our research experts:
Multi-class Combination Product Segment is Expected to Register a Significant Growth Over the Forecast Period.
Based on drug class, the multiclass combination product segment is expected to register significant growth in the forecast years. The development of multiclass combination products is the rising burden of HIV and new drug approval. Also, many companies focus on developing breakthrough products for treating antiretroviral drugs to maintain their competitive advantage and penetrate new regional markets.
The increasing number of HIV cases globally and the effectiveness of multiclass combination product drugs for its treatment is increasing the demand for these drugs, thereby driving the growth of this segment. For instance, an article published by the journal Nanomaterials in February 2021 reported the significant results of using multiclass combination product therapy for reducing HIV symptoms. Similarly, the 2022 UNAIDS factsheet said that 38.4 million HIV infections were globally reported in 2021. The HIV cases increased by 1.6% compared to the previous year, 2020. Thus the increase in HIV cases coupled with the effectiveness of multiclass combination products for treating retroviral infection (HIV infection) is propelling the growth of this segment.
Furthermore, the new combination therapy approaches by various market players and institutes are also driving the growth of this segment. For instance, in November 2021, UK's National Institute for Health and Care Excellence published a draft guidance recommending the country's one of the first long-acting injectable treatments for HIV-1 infection in adults. The recommended treatment was a combination of the injections of cabotegravir with rilpivirine. NICE has recommended the combination as an option for adults with HIV-1 infection in those cases when antiretroviral medicines have kept viral loads to low levels, and there was no evidence of viral resistance. Thus, such guidelines for the newer treatment regime are expected to drive the growth of the studied market segment.
Thus, due to the rising burden of HIV cases and the advantages associated with multi-combination products for reducing HIV symptoms, the studied segment is expected to witness considerable growth over the forecast period.
North America is Expected to Witness a Significant Growth Over the Forecast Period.
North America is expected to witness significant growth over the forecast period owing to the presence of key market players, technological advancements, and the presence of a high number of HIV cases.
The increasing number of HIV cases in North American countries demands an increasing need for anti-retroviral drugs. For instance, in February 2022, News Medical Lifesciences reported a new HIV outbreak in Tijuana, Mexico, driven in part by drug tourism unabated by the closure of the international border due to the COVID-19 pandemic. Similarly, in July 2022, Health Canada Statistics reported that an estimated 62,790 people were living with HIV in Canada at the end of 2020. Thus, a high number of people living with HIV and the increasing spread of HIV are increasing the demand for anti-retroviral drugs, thereby driving the growth of the studied market in the region.
Furthermore, drug approvals and product launches are also driving the growth of the market. For instance, in December 2021, the USFDA approved Apretude for use in at-risk adults and adolescents for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV. Apretude is given first as two initiation injections administered one month apart, and then every two months thereafter. The safety and efficacy of Apretude to reduce the risk of acquiring HIV were evaluated in two randomized, double-blind trials that compared Apretude to Truvada, a once-daily oral medication for HIV PrEP. Thus, such approvals and new drug launches are propelling the growth of the studied market in the region.
Thus, due to the presence of key market players, technological advancements, and increasing research and development the market is expected to witness lucrative growth over the forecast period.
